PER 2.38% 8.2¢ percheron therapeutics limited

announcement, page-88

  1. 965 Posts.
    lightbulb Created with Sketch. 3
    Hi all,

    I know I said I'd drift back into the shadows but just wanted to acknowledge mmq's post appreciate the thought - we're all here for the same reason so bring on the multiple dose results in Dec.

    As I'll hide away again until something more exciting happens with the SP, I'd like to quickly comment on the run in March that has been sneakily talked down in a few posts. Note that PRR and BNO began their run AFTER ANP's in March. ANP's run appeared to be a direct result of the ATL1101 announcement rather than simply a piggyback of other biotech's running at the time. ATL's run occurred the day after the ATL1101 announcement and the runs of BNO and PRR occurred in subsequent days.

    Lastly - I did some DD on BLT and the RNA technology and have to agree with Rob* in that BLT is a different beast altogether and is tough to compare ANP. Also the stock doesn't appeal to me one bit, but that's just my personal opinion, as is everything else i've written in this post.

    Cheers,
    Lok
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
-0.002(2.38%)
Mkt cap ! $73.92M
Open High Low Value Volume
8.2¢ 8.2¢ 8.1¢ $24.83K 304.8K

Buyers (Bids)

No. Vol. Price($)
1 61071 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 21678 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.